Nine-figure deals highlight momentum of Stamford biotech firms
Nine-figure deals highlight momentum of Stamford biotech firms STAMFORD — Biotech firms Cara Therapeutics and SpringWorks Therapeutics have announced in the past week licensing and acquisition deals for two of their under-development drugs that could be worth several hundred million dollars. Cara signed a deal with Vifor Pharma for the commercialization across the entire U.S. […]
Read More